{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T20:53:29Z","timestamp":1793566409214,"version":"4.5.0"},"reference-count":84,"publisher":"Informa Healthcare","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1185\/030079904125002982","type":"journal-article","created":{"date-parts":[[2006,5,17]],"date-time":"2006-05-17T15:36:49Z","timestamp":1147880209000},"page":"369-379","source":"Crossref","is-referenced-by-count":203,"title":["Uric acid: role in cardiovascular disease and effects of losartan"],"prefix":"10.1185","volume":"20","author":[{"given":"Michael","family":"Alderman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kala J. V.","family":"Aiyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2004,1,19]]},"reference":[{"key":"CIT0001","first-page":"1421","volume":"34","author":"Gertler MM","year":"1951","journal-title":"Serum uric acid in relation to age and physique in health and coronary heart disease. Ann Intern Med"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.34.1.144"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4892(02)00143-1"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(66)90005-5"},{"key":"CIT0006","first-page":"637","volume":"141","author":"Freedman DS","year":"1995","journal-title":"The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol"},{"key":"CIT0007","first-page":"225","volume":"33","author":"Johnson RJ","year":"1999","journal-title":"Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370040027005"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.59.5.969"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1159\/000186593"},{"key":"CIT0011","first-page":"2404","volume":"283","author":"Fang J","year":"2000","journal-title":"National Health and Nutrition Examination Survey. JAMA"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.36.6.1072"},{"key":"CIT0013","first-page":"457","volume":"275","author":"Cannon PJ","year":"1966","journal-title":"Hyperuricemia in primary and renal hypertension. N Engl J Med"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200209000-00001"},{"key":"CIT0015","first-page":"501","volume":"48","author":"Turnheim K","year":"1999","journal-title":"Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects. Br J Clin Pharmacol"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.12.2.193"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1159\/000046298"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(98)70067-8"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470210076036"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90106-2"},{"key":"CIT0023","first-page":"779","volume":"16","author":"Timar O","year":"2000","journal-title":"Levy E. Metabolic syndrome X: a review. Can J Cardiol"},{"key":"CIT0025","first-page":"401","volume":"132","author":"Klein R","year":"1973","journal-title":"Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med"},{"key":"CIT0026","first-page":"136","volume":"10","author":"Moriarity JT","year":"2000","journal-title":"Rosamond WD. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-1-199907060-00003"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)60816-1"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200018080-00021"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000065637.10517.A0"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000066420.36123.35"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)02155-5"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.3.635"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1986.179"},{"key":"CIT0037","first-page":"667","volume":"62","author":"Gonick HC","year":"1965","journal-title":"Arch Intern Med"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-196012000-00001"},{"key":"CIT0039","first-page":"999","volume":"60","author":"Ginsberg MH","year":"1977","journal-title":"Release of platelet constituents by monosodium urate crystals. J Clin Invest"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/0306-9877(75)90011-0"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1161\/hy1101.092839"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00283.2001"},{"key":"CIT0043","first-page":"511","volume":"49","author":"Waring WS","year":"2000","journal-title":"Effect of local hyperuricemia on endothelial function in the forearm vascular bed (abstract). Br J Clin Pharmacol"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.37.12.1210"},{"key":"CIT0045","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/oxfordjournals.aje.a115593","volume":"131","author":"Selby JV","year":"1990","journal-title":"Am J Epidemiol"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000017502.58595.ED"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a015352"},{"key":"CIT0049","first-page":"1207","volume":"89","author":"Mustard JF","year":"1963","journal-title":"Can Med Assoc J"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1080\/08037050310060508"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/0306-9877(75)90011-0"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.442"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1159\/000045939"},{"key":"CIT0054","first-page":"34","volume":"15","author":"Syrjanen J","year":"2000","journal-title":"Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant"},{"key":"CIT0056","unstructured":"Insel PA. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A, eds. Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1996:617\u201357"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780190209"},{"key":"CIT0058","first-page":"701","volume":"59","author":"Masbernard A","year":"1981","journal-title":"S Afr Med J"},{"key":"CIT0059","first-page":"263","volume":"519","author":"Pfister B","year":"1978","journal-title":"Effect of sulphinpyrazone (Anturan) on uric acid excretion and plasma uric acid concentration in healthy volunteers. Eur J Clin Pharmacol"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1999.tb00701.x"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03491-7"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.14.2185"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)02953-9"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90068-0"},{"key":"CIT0065","first-page":"814","volume":"43","author":"Iwatani M","year":"2000","journal-title":"Troglitazone decreases serum uric acid concentrations in type II diabetic patients and non-diabetics. Diabetologia"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.268"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.22.3.339"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90163-9"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.41.793"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199807270-00023"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200110000-00021"},{"key":"CIT0072","first-page":"347","volume":"20","author":"Liberopoulos E","year":"2002","journal-title":"Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and gout. J Hypertens"},{"key":"CIT0073","first-page":"1186","volume":"22","author":"Manolis AJ","year":"2000","journal-title":"Losartan Trial Investigators. Clin Ther"},{"key":"CIT0074","first-page":"1033","volume":"17","author":"Puig JG","year":"1999","journal-title":"Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension. J Hypertens"},{"key":"CIT0075","first-page":"421","volume":"82","author":"Campion EW","year":"1987","journal-title":"Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2560"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.3317\/jraas.2000.045"},{"key":"CIT0078","first-page":"112","volume":"26","author":"Soffer BA","year":"1995","journal-title":"Effects of losartan on a background of hydrochlorothiazide in patients with hypertension. Hypertension"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430040081010"},{"key":"CIT0080","first-page":"839","volume":"280","author":"Roch-Ramel F","year":"1997","journal-title":"Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles. J Pharmacol Exp Ther"},{"key":"CIT0081","first-page":"F797\u2013F805","volume":"266","author":"Roch-Ramel F","year":"1994","journal-title":"Urate transport in brush-border membrane of human kidney. Am J Physiol"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00739.x"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000017502.58595.ED"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1136\/heart.87.3.229"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90950-M"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(91)91433-V"},{"key":"CIT0087","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-5223(19)36703-0","volume":"101","author":"Tabayashi K","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199448030-00002"},{"key":"CIT0089","first-page":"270","volume":"3","author":"Ricardo SD","year":"1995","journal-title":"Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol. Exp Nephrol"},{"key":"CIT0090","first-page":"454","volume":"320","author":"Gryglewski RJ","year":"1986","journal-title":"Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08089-3"},{"key":"CIT0093","first-page":"339","volume":"18","author":"Owens P","year":"2000","journal-title":"Comparison of antihypertensive and metabolic effects of losartan and losartan in combination with hydrochlorothiazide \u2013 a randomized controlled trial. J Hypertens"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079904125002982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T22:27:05Z","timestamp":1586903225000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079904125002982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,19]]},"references-count":84,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,12,22]]},"published-print":{"date-parts":[[2004,3]]}},"alternative-id":["10.1185\/030079904125002982"],"URL":"https:\/\/doi.org\/10.1185\/030079904125002982","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,19]]}}}